The manufacturers behind 15 drugs selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act [...] …
Category: General
The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The budget reconciliation process and President Donald Trump’s (R) priorities are expected to continue dominating Washington D.C. politics in the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …